Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 59
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Exp Med ; 152(1): 138-50, 1980 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-6967509

RESUMEN

Cultures of isolated mouse splenic B lymphocytes activated by the divalent F(ab')2 fragment of purified rabbit anti-mouse Fab or class-specific anti-mouse IgM antibodies can be driven on to high rate Ig secretion by the addition of the supernatant fluid of a 24-h culture of concanavalin A-activated spleen cells (SN). The polyclonal antibody response to anti-Ig pus SN is comparable in magnitude with the lipopolysaccharide response as measured in a reverse plaque assay. The addition of SN can be delayed for 24 h after addition of anti-Ig without changing the kinetics of the response. Addition at 48 h delays the response by 24 h. The response to F(ab')2 anti-Fab plus SN is sensitive to Fc-dependent inhibition because intact anti-Fab antibodies inhibit strongly at relatively low concentrations. The monovalent Fab' fragment fails to induce Ig secretion, indicating that cross-linkage of surface immunoglobulin is required. Although the production of active SN is T cell dependent, the response to anti-Ig plus SN is T independent. These findings are interpreted as a polyclonal model of a thymus-dependent antibody response. X


Asunto(s)
Anticuerpos Antiidiotipos/inmunología , Linfocitos B/inmunología , Inmunoglobulinas/metabolismo , Activación de Linfocitos , Animales , Especificidad de Anticuerpos , Linfocitos B/ultraestructura , Células Cultivadas , Femenino , Fragmentos Fc de Inmunoglobulinas/inmunología , Inmunoglobulinas/inmunología , Lipopolisacáridos/inmunología , Masculino , Ratones , Microscopía Electrónica , Conejos , Bazo/inmunología , Linfocitos T/inmunología , Factores de Tiempo
2.
Cancer Res ; 61(8): 3250-5, 2001 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-11309274

RESUMEN

During embryogenesis, blood vessels are formed initially by the process of vasculogenesis, the in situ differentiation of mesenchymal cells into endothelial cells, which form a primitive, patterned vasculogenic network. This is followed by angiogenesis, the sprouting of new vessels from preexisting vasculature, to yield a more refined microcirculation. However, we and our collaborators have recently described a process termed "vasculogenic mimicry," which consists of the formation of patterned, tubular networks by aggressive melanoma tumor cells (in three-dimensional cultures in vitro), that mimics endothelial-formed vasculogenic networks and correlates with poor clinical prognosis in patients. Previous microarray analysis from our laboratory comparing the highly aggressive versus the poorly aggressive melanoma cells revealed a significant increased expression of tyrosine kinases associated with the aggressive melanoma phenotype. Because of the important role of protein tyrosine kinases in phosphorylating various signal transduction proteins that are critical for many cellular processes (e.g., cell adhesion, migration, and invasion), we examined whether protein tyrosine kinases are involved in melanoma vasculogenic mimicry. Immunofluorescence analysis of aggressive melanoma cells forming tubular networks in vitro showed that tyrosine phosphorylation activity colocalized specifically within areas of tubular network formation. A phosphotyrosine profile of the aggressive melanoma cells capable of forming tubular networks indicated differences in tyrosine phosphorylated proteins compared with the poorly aggressive melanoma cells (incapable of forming tubular networks). Most notably, we identified epithelial cell kinase (EphA2) as being one receptor tyrosine kinase expressed and phosphorylated exclusively in the aggressive metastatic melanoma cells. Furthermore, general inhibitors of protein tyrosine kinases hindered tube formation, and transient knockout of EphA2 abrogated the ability of tumor cells to form tubular structures. These results suggest that protein tyrosine kinases, particularly EphA2, are involved in the formation of tubular networks by aggressive melanoma tumor cells in vitro, which may represent a novel therapeutic target for further clinical investigation.


Asunto(s)
Melanoma/enzimología , Melanoma/patología , Neovascularización Patológica/enzimología , Proteínas Tirosina Quinasas Receptoras/fisiología , Neoplasias de la Úvea/enzimología , Neoplasias de la Úvea/patología , Humanos , Melanoma/irrigación sanguínea , Neovascularización Patológica/patología , Oligonucleótidos Antisentido/farmacología , Fosforilación , Proteínas Tirosina Quinasas Receptoras/biosíntesis , Proteínas Tirosina Quinasas Receptoras/metabolismo , Receptor EphA2 , Células Tumorales Cultivadas , Tirosina/metabolismo , Neoplasias de la Úvea/irrigación sanguínea
3.
J Dent Res ; 84(6): 542-7, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15914592

RESUMEN

Three-dimensional environments have been shown to enhance cell aggregation and osteoblast differentiation. Thus, we hypothesized that three-dimensional (3D) growth environments would enhance the mineralization rate of human embryonic palatal mesenchymal (HEPM) pre-osteoblasts. The objective of this study was to investigate the potential use of rotary cell culture systems (RCCS) as a means to enhance the osteogenic potential of pre-osteoblast cells. HEPM cells were cultured in a RCCS to create 3D enviroments. Tissue culture plastic (2D) cultures served as our control. 3D environments promoted three-dimensional aggregate formations. Increased calcium and phosphorus deposition was significantly enhanced three- to 18-fold (P < 0.001) in 3D cultures as compared with 2D environments. 3D cultures mineralized in 1 wk as compared with the 2D cultures, which took 4 wks, a decrease in time of nearly 75%. In conclusion, our studies demonstrated that 3D environments enhanced osteoblast cell aggregation and mineralization.


Asunto(s)
Calcificación Fisiológica/fisiología , Técnicas de Cultivo de Célula/métodos , Osteoblastos/fisiología , Calcio/metabolismo , Agregación Celular/fisiología , Colorantes , Microanálisis por Sonda Electrónica , Humanos , Mesodermo/citología , Microscopía Electrónica de Rastreo , Osteogénesis/fisiología , Hueso Paladar/embriología , Fósforo/metabolismo , Rotación , Factores de Tiempo
4.
J Dent Res ; 84(11): 1070-4, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16246944

RESUMEN

Osteoblast differentiation and extracellular matrix production are pivotal processes for implant osseointegration or bone tissue engineering. We hypothesized that a biomimetic coating on titanium surfaces, consisting of apatite and amelogenin, would promote such processes. Human Embryonic Palatal Mesenchymal pre-osteoblasts were used as a model for the evaluation of cell adhesion and spreading patterns, as well as mRNA expression of certain osteoblastic gene products. Real-time PCR showed significant (p < 0.05) increase in expression of type I collagen, alkaline phosphatase, and osteocalcin from cells grown on titanium with an apatite/amelogenin composite, as compared with that from cells grown on a pure titanium or apatite coating only. Osteocalcin expression was specifically stimulated by amelogenin added to the culture media. Enhanced attachment and cell spreading were also observed. The biomimetic coating promoting cell adhesion and osteoblast differentiation may have great potential for future dental and biomedical applications.


Asunto(s)
Apatitas/farmacología , Materiales Biocompatibles Revestidos/farmacología , Proteínas del Esmalte Dental/farmacología , Osteoblastos/efectos de los fármacos , Osteogénesis/genética , Titanio/química , Fosfatasa Alcalina/análisis , Amelogenina , Apatitas/química , Materiales Biomiméticos/química , Adhesión Celular/efectos de los fármacos , Diferenciación Celular/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Células Cultivadas , Materiales Biocompatibles Revestidos/química , Colágeno Tipo I/análisis , Proteínas del Esmalte Dental/química , Matriz Extracelular/efectos de los fármacos , Regulación de la Expresión Génica , Humanos , Mesodermo/citología , Mesodermo/efectos de los fármacos , Oseointegración/efectos de los fármacos , Osteocalcina/análisis , Osteogénesis/efectos de los fármacos
5.
J Bone Miner Res ; 3(2): 225-32, 1988 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-2905573

RESUMEN

Osteopetrosis in the ia (incisors absent) rat is the result of reduced bone resorption due to abnormal osteoclasts. This mutant and others have been used to determine the precursor(s) to osteoclasts. Hemopoietic stem cells, isolated from bone marrow of normal littermates, cure the skeletal sclerosis and result in the formation of normal osteoclasts when transplanted into ia rats. These studies were conducted to define further the precursor to the osteoclast by evaluating the effects of the transplantation of granulocyte-macrophage progenitors on bone resorption in the ia rat. Granulocyte-colony forming cells (G-CFC), granulocyte-macrophage-colony forming cells (GM-CFC), and macrophage-colony forming cells (M-CFC) were isolated from normal bone marrow using an FITC-labeled monoclonal antibody directed against rat Thy-1.1 and fluorescence-activated cell sorting. The isolates were evaluated in soft agar culture; granulocyte isolates generated 71% G-CFC of all colonies formed and were enhanced 27 times over unfractionated cells. Mixed isolates generated 57% GM-CFC of all colonies formed and were 15 times enhanced, while macrophage isolates were 75% M-CFC with an enhancement factor of 18. The isolated populations were injected into 3-week-old ia recipients and evaluated for the ability of these cellular isolates to correct the bone resorption defect by measuring the size of the tibial marrow cavity and by identifying morphologically normal osteoclasts. In addition, isolated populations of cells were labeled with FITC and injected into ia donors to determine if labeled osteoclasts developed.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Resorción Ósea , Granulocitos/trasplante , Trasplante de Células Madre Hematopoyéticas , Macrófagos/trasplante , Osteopetrosis/fisiopatología , Animales , Ensayo de Unidades Formadoras de Colonias , Citometría de Flujo , Granulocitos/citología , Células Madre Hematopoyéticas/citología , Macrófagos/citología , Ratas , Ratas Mutantes , Trasplante de Piel
6.
J Bone Miner Res ; 9(4): 585-91, 1994 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8030447

RESUMEN

Osteopetrois is an inherited bone disease characterized by an excessive accumulation of bone throughout the skeleton. The disease in the ia (incisors absent) rat is the result of reduced bone resorption caused by defective, although numerous osteoclasts. In addition to the bone defects, ia rats have suppressed natural immunity, even though these animals have excessive numbers of natural killer (NK) cells. The osteopetrotic condition also appears to have an associated abnormality in vitamin D metabolism. Because 1,25-dihydroxyvitamin D3[1,25-(OH)2D3] stimulates bone resorption and has a role in the immunoregulation of NK cells, mutant and normal rats were infused with 1,25-(OH)2D3 for 14 days in an attempt to correct the defects in this mutant. Serum levels of osteocalcin, 25-OHD3, and 1,25-(OH)2D3, as well as NK function and parameters of bone resorption, were evaluated after the infusion period. Serum levels of osteocalcin and 1,25-(OH)2D3 were elevated in both ia and normal rats treated with 1,25-(OH)2D3. Serum 25-OHD3 levels were significantly reduced in the treated animals. The elevated percentage of NK cells normally found in ia rats was reduced to normal in the treated mutants, and NK cell function was elevated to normal levels of lytic activity. The percentage of NK cells and NK function remained unchanged in the treated normal rats. The bone marrow cavity size was significantly increased in the 1,25-(OH)2D3-treated mutants, as was the percentage of osteoclasts exhibiting normal morphology. Radiographically, the mutant bones were less dense.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Resorción Ósea/tratamiento farmacológico , Calcitriol/farmacología , Inmunidad Innata/efectos de los fármacos , Osteopetrosis/tratamiento farmacológico , Animales , Médula Ósea/patología , Remodelación Ósea/efectos de los fármacos , Calcifediol/sangre , Calcitriol/sangre , Citotoxicidad Inmunológica , Células Asesinas Naturales/efectos de los fármacos , Células Asesinas Naturales/inmunología , Osteocalcina/sangre , Osteoclastos/patología , Osteopetrosis/inmunología , Osteopetrosis/patología , Ratas , Ratas Mutantes
7.
J Bone Miner Res ; 7(8): 941-9, 1992 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-1442208

RESUMEN

Recent studies have provided evidence that cells of the immune system and their associated cytokines function in the regulation of bone turnover. The incisors absent (ia) osteopetrotic rat represents a model in which a defect in the immune system and bone resorption can be studied. Osteopetrosis in the ia rat is characterized by a generalized excess accumulation of bone as a result of reduced bone resorption by defective osteoclasts that lack a ruffled border and the ability to exocytose their osteolytic enzymes. Previous attempts to identify associated defects in the ia immune system have proven unsuccessful; ia rats demonstrate normal delayed hypersensitivity, mitogenic activity, and macrophage function. Inasmuch as the skeletal manifestations of the ia mutation may be the result of a defect in exocytosis, related defects may be evident in immune cells utilizing exocytosis of granules or enzymes for their cytolytic function. Natural killer (NK) cells function by such a mechanism. Therefore, these studies were undertaken to evaluate the natural immune system in ia rats. NK activity assessed by 51Cr release assays was significantly reduced in ia animals compared to normal littermates. Mononuclear cells isolated from the peripheral blood of ia rats revealed a significantly greater percentage of large granular lymphocytes than normal littermates. Comparison of NK cell phenotypes using two phenotypic parameters for NK cells (OX8+, OX19- cells and 3.2.3+ cells) revealed that the mononuclear isolates of spleen and peripheral blood of mutant animals had significantly greater percentages of OX8+, OX19- and 3.2.3+ cells than normal controls.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Células Asesinas Naturales/inmunología , Osteopetrosis/inmunología , Animales , Citotoxicidad Inmunológica/efectos de los fármacos , Modelos Animales de Enfermedad , Indometacina/farmacología , Interleucina-2/farmacología , Recuento de Leucocitos , Mutación , Fenotipo , Ratas , Ratas Mutantes
8.
Bone ; 6(4): 241-7, 1985.
Artículo en Inglés | MEDLINE | ID: mdl-2864942

RESUMEN

Osteopetrosis in the ia rat is the result of reduced bone resorption due to abnormal osteoclasts. Studies in the ia mutant have shown that mononuclear cells from normal littermates could cure the skeletal sclerosis and result in the formation of normal osteoclasts when transplanted into ia rats. Recent studies demonstrated that the Ficoll-Hypaque isolates of spleen, bone marrow, and newborn liver were effective in curing the skeletal disease. These results suggest that the cellular source of the cure is a pluripotent hemopoietic stem cell (PHSC). Goldschneider et al. (1980) demonstrated that stem cells from rat bone marrow relatively large mononuclear cells that are strongly positive for Thy 1.1 antigen. Splenic and bone marrow samples from normal rats were treated with a monoclonal antibody developed against the rat Thy 1.1 antigen and guinea pig complement. This procedure was cytotoxic for 47% of the mononuclear spleen cells and 74% of the mononuclear bone marrow cells. When the Thy 1.1 depleted samples were transplanted into ia littermates, they were ineffective in reversing the osteoclast and bone resorption defects. Using the parameters described by Goldschneider, and fluorescence-activated cell sorting (FACS), the PHSC were isolated from normal rat bone marrow. The isolated cells were assayed for colony forming units--spleen (CFU-S) and were found to contain approximately 65-70% PHSC. Two, 3, and 5-week-old ia rats were given an intraperitoneal injection of normal bone marrow stem cells (1.4 X 10(4) to 7.0 X 10(4) cells).(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Separación Celular/métodos , Trasplante de Células Madre Hematopoyéticas , Osteopetrosis/terapia , Animales , Diferenciación Celular , Proteínas del Sistema Complemento/inmunología , Citometría de Flujo , Células Madre Hematopoyéticas/citología , Isoanticuerpos/inmunología , Osteoclastos/patología , Osteopetrosis/patología , Ratas
9.
Bone ; 9(5): 303-8, 1988.
Artículo en Inglés | MEDLINE | ID: mdl-3203017

RESUMEN

Studies involving bone marrow transplantation of osteopetrotic rodents have provided evidence for the lineage of the osteoclast. Recent investigations have demonstrated that isolates of bone marrow containing an enriched population of granulocyte-colony-forming cells (G-CFC) or granulocyte macrophage-colony-forming cells (GM-CFC) from normal animals cure the skeletal sclerosis and result in the formation of normal osteoclasts when transplanted into ia osteopetrotic rats. Macrophage-colony-forming cell isolates were ineffective in this transplant system. A criticism of these findings is that the microenvironment of the osteopetrotic bone and the bone marrow compartment may be unique in their ability to induce the differentiation of these stem cells into osteoclasts. To test this hypothesis, G-CFC, GM-CFC, and M-CFC were co-cultured with fetal metatarsal bones form normal animals. The CFC were isolated from normal bone marrow using FITC-labeled monoclonal antibodies directed against rat Thy 1.1 and fluorescence-activated cell sorting. The isolates were evaluated in soft agar culture; granulocyte isolates generated 74% G-CFC of all colonies formed and were enhanced 30 times over unfractionated cells. Mixed isolates generated 60% GM-CFC of the colonies formed and were 12 times enhanced, while macrophage isolates were 77% M-CFC with an enhancement factor of 28. The various CFC isolates or whole mononuclear bone marrow were co-cultured with 20-day fetal rat metatarsal rudiments for 7 days and then prepared for light and electron microscopy. The number of osteoclasts generated in vitro by each isolate was determined.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Médula Ósea/fisiología , Células Madre Hematopoyéticas/fisiología , Osteoclastos/fisiología , Animales , Células de la Médula Ósea , Ensayo de Unidades Formadoras de Colonias , Técnicas de Cultivo , Femenino , Feto , Granulocitos/fisiología , Macrófagos/fisiología , Masculino , Microscopía Electrónica , Osteoclastos/ultraestructura , Ratas , Ratas Endogámicas
10.
Bone ; 18(1): 47-52, 1996 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-8717536

RESUMEN

The regulation of bone deposition and remodeling is highly complex. To further understand the influence of growth hormone on bone deposition, several lines of transgenic mice were generated that expressed the human growth hormone gene (hGH) driven by beta-globin regulatory elements. In situ hybridization confirmed that the hGH gene in these mice was expressed in an erythroid tissue-specific manner; in the fetus hGH was expressed in the liver and in the adult mice hGH was expressed in the bone marrow. The bones of mice in two lines were visualized radiographically by mammography, and relative bone densities were measured. The transgenic mice had detectably more bone density than nontransgenic littermate controls by approximately 3 weeks of age and the relative difference in density increased with age. Histological cross-sections of the tibia showed that adult transgenic mice had increased average cortical bone thickness when compared to their controls. The hypothesis is that the local effect of hGH release from differentiating erythroid cells in the bone marrow is a major contributor to the increased bone deposition in these transgenic mice.


Asunto(s)
Densidad Ósea/fisiología , Huesos/anatomía & histología , Células Precursoras Eritroides/metabolismo , Globinas/genética , Hormona del Crecimiento/genética , Regiones Promotoras Genéticas , Animales , Mapeo Cromosómico , Femenino , Hormona del Crecimiento/biosíntesis , Humanos , Masculino , Ratones , Ratones Transgénicos , Proteínas Recombinantes/biosíntesis
11.
Bone ; 24(4): 321-7, 1999 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10221544

RESUMEN

In this study, the expression of beta3-integrin was examined in relationship to the restricted expression of bone sialoprotein (BSP). Immunohistochemical analysis indicated that the alpha(v)beta3-integrin was coincident and proximal to BSP expression in the fetal mandible bovine osteoblast culture model. Alpha(v)beta3-integrin expression was expressed predominantly in a region proximal to, but not including, the substrate adherent cells. In comparison, the alpha5beta1-integrin was expressed in a generalized pattern throughout the culture layers in a coordinated fashion to fibronectin. The temporal expression of beta1- and beta3-integrin was evaluated using RT-PCR and southern blot analysis. Unlike the generalized expression of beta1-integrin, beta3-integrin was restricted to days 3 and 5 of the culture period. The previous demonstration of similar restriction of BSP expression and the present colocalization of BSP suggests the potential coordinated expression of a specific extracellular matrix ligand with a select integrin. Beta3-integrin/BSP adhesion-mediated signaling may play a significant role in the process of osteoblast morphodifferentiation.


Asunto(s)
Antígenos CD/biosíntesis , Osteoblastos/metabolismo , Glicoproteínas de Membrana Plaquetaria/biosíntesis , Sialoglicoproteínas/biosíntesis , Animales , Southern Blotting , Bovinos , Adhesión Celular/fisiología , Diferenciación Celular/fisiología , Células Cultivadas , Fibronectinas/análisis , Inmunohistoquímica , Integrina beta3 , Sialoproteína de Unión a Integrina , Osteoblastos/citología , ARN Mensajero/biosíntesis , Receptores de Vitronectina/análisis , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
12.
Bone ; 19(6): 575-9, 1996 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-8968022

RESUMEN

The oim strain of mice is one of several rodent models that exhibit an osteogenesis imperfecta (OI) phenotype. These mice have a mutation in the gene encoding alpha-2 chain of type I procollagen that prevents proper assembly of this propeptide with alpha-1 propeptides. Homozygous oim mice experience multiple bone fractures under standard laboratory animal housing conditions and are representative of moderate to severe forms of OI. Because fractures are not typically experienced by heterozygous oim mice, they have not been studied extensively. The present studies show that the organization of cortical bone is deficient in heterozygotes, exhibiting a morphology intermediate to specimens from homozygotes and wild-type mice. The biomechanical properties of femurs isolated from heterozygous oim mice are also intermediate to homozygotes and wild-type mice when tested in four-point bending. Although it is not possible to distinguish visually between heterozygous oim and wild-type mice, the quality and biomechanical properties of bone in heterozygotes is significantly reduced by twelve weeks of age. Heterozygous oim mice are useful as a model for a mild form of OI.


Asunto(s)
Huesos/lesiones , Heterocigoto , Osteogénesis Imperfecta/etiología , Animales , Fenómenos Biomecánicos , Huesos/fisiopatología , Diáfisis/patología , Modelos Animales de Enfermedad , Femenino , Fracturas del Fémur/genética , Fracturas del Fémur/fisiopatología , Masculino , Ratones , Ratones Mutantes , Osteogénesis Imperfecta/genética , Fenotipo , Tibia/patología
13.
Bone ; 16(6): 657-62, 1995 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-7669443

RESUMEN

Osteopetrosis is a heterogeneous group of bone diseases characterized by an excess accumulation of bone and a variety of immune defects. Osteopetrosis (op) and incisors absent (ia) are two nonallelic mutations in the rat which demonstrated these skeletal defects as a result of reduced bone resorption. Osteopetrotic (op) rats have severe sclerosis as a result of reduced numbers of osteoclasts which are structurally abnormal. The sclerosis in ia rats is not as severe as in op mutants; they have elevated numbers of osteoclasts, but they are also morphologically abnormal, lacking a ruffled border. Both of these mutations have defects in the inflammation-primed activation of macrophages. They demonstrate independent defects in the cascade involved in the conversion of vitamin D binding protein (DBP) to a potent macrophage activating factor (DBP-MAF). Because this factor may also play a role in the pathogenesis of osteoclastic dysfunction, the effects of ex vivo-generated DBP-MAF were evaluated on the skeletal system of these two mutations. Newborn ia and op rats and normal littermate controls were injected with DBP-MAF or vehicle once every 4 days from birth until 2 weeks of age, at which time bone samples were collected to evaluate a number of skeletal parameters. DBP-MAF treated op rats had an increased number of osteoclasts and the majority of them exhibited normal structure. There was also reduced bone volume in the treated op animals and an associated increased cellularity of the marrow spaces. The skeletal sclerosis was also corrected in the ia rats; the bone marrow cavity size was significantly enlarged and the majority of the osteoclasts appeared normal with extensive ruffled borders.


Asunto(s)
Resorción Ósea/tratamiento farmacológico , Factores Activadores de Macrófagos/farmacología , Osteopetrosis/tratamiento farmacológico , Proteína de Unión a Vitamina D/farmacología , Animales , Médula Ósea/efectos de los fármacos , Médula Ósea/patología , Células de la Médula Ósea , Modelos Animales de Enfermedad , Factores Activadores de Macrófagos/administración & dosificación , Factores Activadores de Macrófagos/uso terapéutico , Microscopía Electrónica , Mutación/efectos de los fármacos , Mutación/genética , Osteoclastos/citología , Osteoclastos/efectos de los fármacos , Osteoclastos/metabolismo , Osteoclastos/patología , Osteopetrosis/genética , Oxidación-Reducción , Ratas , Tibia/efectos de los fármacos , Tibia/patología , Tibia/ultraestructura , Proteína de Unión a Vitamina D/administración & dosificación , Proteína de Unión a Vitamina D/uso terapéutico
14.
Immunobiology ; 167(4): 318-27, 1984 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-6334646

RESUMEN

Osteopetrosis in ia rats is characterized by excessive skeletal mass and reduced bone resorption. The skeletal defects can be corrected by the transfer of mononuclear spleen cells from normal littermates. These studies suggest that osteopetrotic mutants may also have defective immune functions. The op, osteopetrotic, rat demonstrates early thymic atrophy and immune function which decreases with age. Several studies have shown significantly reduced responses to T and B cell mitogens by spleen cells from osteopetrotic mutant mice. The problem with these latter studies is that different populations of cells have been compared in mutants and normal littermates because the spleen is a focus of extramedullary hemopoiesis in osteopetrotic animals. To circumvent this problem, the Ficoll-Hypaque, mononuclear isolate of spleen and mesenteric lymph node from 5-week-old ia and normal littermates were compared. Under appropriate culture conditions the cells were exposed to Con A, PHA, and LPS for 3 days and 3H-thymidine for the last 24 hours. In all cases, the response to optimal concentrations of the 3 mitogens was similar for ia and normal spleen and lymph node cells (ia/control ratios ranged from 0.6 to 1.2). The cellular composition of the samples tested in the mitogen assays were also evaluated by fluorescent microscopy using FITC-conjugated monoclonal antibodies directed against specific cell surface markers. The percentage of B cells, macrophages, total T cells, and helper T cells were found to be similar in the Ficoll-Hypaque isolate of ia and normal spleen and lymph nodes. Likewise, the ia mutant does not show any signs of abnormal thymic involution. These results indicate normal immune function in the ia mutant when similar populations of cells are compared.


Asunto(s)
Osteopetrosis/inmunología , Animales , Linfocitos B/inmunología , Ganglios Linfáticos/inmunología , Activación de Linfocitos , Mitógenos/farmacología , Mutación , Osteopetrosis/genética , Ratas , Bazo/inmunología , Linfocitos T/inmunología , Timo/inmunología
15.
J Dent Res ; 80(6): 1540-4, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11499509

RESUMEN

Integrin adhesion and signaling events may contribute to the progressive differentiation of the osteoblast and to the initiation of a mineralized matrix. The purpose of our study was to begin to analyze the role of integrin receptors, in particular alpha2beta1, alpha5beta1, and alphaVbeta3, regarding mediation of the initiation of a mineralized matrix. Integrin-perturbation assays were conducted in microdot cultures of UMR-106-01 Bone Sialoprotein (BSP) osteoblast cells. For phenotypic analysis, we performed bright-field microscopy and Aliziran Red S staining to analyze effects on mineralization initiation. Mineralization was reduced significantly (P < 0.001) following the addition of alpha5- or beta1-integrin subunit antibody by approximately 20% and 45%, respectively--alphaVbeta3 integrin by nearly 65%, and alpha2beta1 integrin by nearly 95%. This effect was reversible following the removal of the antiintegrin antibody. These results suggest that integrin adhesion and signaling events may contribute to the ability of this cell line to mediate the initiation of the mineralization phenotype biologically.


Asunto(s)
Adhesión Celular/fisiología , Osteoblastos/metabolismo , Receptores de Citoadhesina/metabolismo , Calcificación de Dientes/fisiología , Análisis de Varianza , Animales , Diferenciación Celular , Relación Dosis-Respuesta Inmunológica , Matriz Extracelular/fisiología , Regulación del Desarrollo de la Expresión Génica , Sialoproteína de Unión a Integrina , Integrinas/metabolismo , Osteosarcoma/metabolismo , Unión Proteica/fisiología , Ratas , Receptores de Colágeno , Receptores de Fibronectina/metabolismo , Receptores de Vitronectina/metabolismo , Sialoglicoproteínas/fisiología , Transducción de Señal , Calcificación de Dientes/genética , Células Tumorales Cultivadas
16.
J Dent Res ; 82(5): 372-6, 2003 May.
Artículo en Inglés | MEDLINE | ID: mdl-12709504

RESUMEN

The transcription factor Cbfa1 regulates osteoblast differentiation and expression of genes necessary for the development of a mineralized phenotype. The purpose of this study was to determine if Cbfa1 and BSPII gene expression are influenced by implant surface microtopography. Osteoblasts were cultured on 600-grit (grooved) or sandblasted (roughened) cpTi implant discs. Mineralization was evaluated by Alizarin-Red-S staining. Real Time PCR was used for quantitative analysis of Cbfa1 and BSPII gene expression. Enhanced mineralization was seen in osteoblasts grown on roughened implant surfaces relative to tissue culture plastic. Real Time PCR showed significant (P < 0.05) increases in Cbfa1 gene expression in cells grown on roughened, as compared with grooved, implant surfaces. BSPII gene expression was also increased on rough surfaces in the UMR cells, but was reduced in the rat calvarial osteoblast cultures. These results suggest that osteoblast gene expression and mineralization are affected by roughened implant surface microtopographies during osseointegration of dental implants.


Asunto(s)
Implantes Dentales , Proteínas de Neoplasias , Oseointegración/fisiología , Osteoblastos/metabolismo , Sialoglicoproteínas/biosíntesis , Factores de Transcripción/biosíntesis , Análisis de Varianza , Animales , Calcificación Fisiológica , Diferenciación Celular , Células Cultivadas , Subunidad alfa 1 del Factor de Unión al Sitio Principal , Expresión Génica , Sialoproteína de Unión a Integrina , Microscopía Electrónica de Rastreo , Ratas , Estadísticas no Paramétricas , Propiedades de Superficie , Titanio
17.
J Morphol ; 174(2): 141-7, 1982 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-7175944

RESUMEN

The reduced bone resorption characteristic of osteopetrosis is accompanied in the incisors-absent (ia) rat mutation by a significant increase in osteoclasts of inactive (mutant) phenotype. Restoration of bone resorption in ia rats by transfer of spleen cells from normal littermates is preceded by a transformation of osteoclasts from mutant to normal phenotype. In this investigation the proportions of osteoclasts of normal phenotype have been determined by light microscopy in untreated ia and normal rats and in ia rats treated with various cell populations from normal rats. Significant increases in numbers of osteoclasts of normal phenotype were seen in the mutant skeleton soon after cell treatments that eventually restored bone resorption and cured the disease. No changes in osteoclast phenotype were seen after cell transfers that did not cure the disease. These data establish transformation of osteoclast phenotype as an early event in the recovery from osteopetrosis and suggest that determination of osteoclast phenotype is a reliable predictor of the success of normal cell populations to restore bone resorption in this mutation.


Asunto(s)
Osteoclastos/fisiología , Osteopetrosis/congénito , Ratas/genética , Animales , Osteoclastos/patología , Osteopetrosis/patología , Fenotipo , Ratas Endogámicas
18.
Arch Oral Biol ; 49(8): 653-64, 2004 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15196983

RESUMEN

This study examines differences between cultures of normal human oral epithelial cells and two squamous cell carcinoma cell lines (SCC15 and SCC25) in the expression of structural proteins, adhesion molecules, plasma membrane lipid composition, and intercellular junctions. Based on immunocytochemistry, most normal cell cultures appeared to express more E-cadherin, integrin beta-1, cytokeratin (CK) 14, CK19, and involucrin than SCC cultures. By Western blot analysis, normal cultures expressing high levels of E-cadherin also expressed high levels of involucrin and low levels of CK19. Both SCC cultures demonstrated lower expression of E-cadherin and involucrin, whereas only SCC15 cells showed high levels of CK19. Expression of beta-catenin, an E-cadherin associated protein with potential oncogene function, did not vary among normal and SCC cells. Proportions of saturated fatty acids quantified by thin layer chromatography were higher in the normal cell cultures, than in both SCC cell lines. No morphological differences were evident by transmission electron microscopy (TEM) between normal and SCC cell-cell intercellular junctions. Although no quantitation was attempted, observation suggested that normal cells form more intercellular junctions (TEM observation) and larger intercellular bridges (SEM observation) compared to both SCC cell lines. Of the factors examined, main variations between cultures of normal oral epithelium and the two SCC cell lines examined include the expression of structural and adhesion proteins, lipid composition, and intercellular junctions. The extent of the differences varies according to the stage of terminal differentiation demonstrated by the normal cell cultures.


Asunto(s)
Biomarcadores de Tumor/análisis , Carcinoma de Células Escamosas/química , Neoplasias de la Boca/química , Western Blotting/métodos , Cadherinas/análisis , Carcinoma de Células Escamosas/ultraestructura , Diferenciación Celular , Línea Celular Tumoral , Células Cultivadas , Ácidos Grasos/análisis , Encía/metabolismo , Encía/ultraestructura , Humanos , Inmunohistoquímica/métodos , Integrina beta1/análisis , Queratinocitos/metabolismo , Queratinocitos/ultraestructura , Queratinas/análisis , Microscopía Electrónica , Neoplasias de la Boca/ultraestructura , Precursores de Proteínas/análisis
19.
Biotech Histochem ; 66(5): 228-35, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1790237

RESUMEN

Tartrate resistant acid phosphatase (TRAP) has been accepted as a marker for identification of osteoclasts. A method is reported here for quantitating TRAP using an image analysis system. The amount of the enzyme specific to osteoclasts can be used to differentiate osteoclasts from other cells capable of TRAP expression. TRAP expression characteristic of the osteoclast was compared with that of multi-nucleated giant cells (MNGC)s recruited to the site of subcutaneously implanted mineralized bone matrix. Two weeks post-implantation, the pellets were removed and processed for the demonstration of TRAP along with rat proximal tibiae. A large amount of TRAP was consistently expressed by the in situ osteoclasts. The MNGCs associated with the mineralized bone implants expressed little if any TRAP reaction product. Using this system, the amount of TRAP reaction product or any other enzyme reaction product expressed can be objectively and reproducibly quantitated.


Asunto(s)
Fosfatasa Ácida/análisis , Tartratos/farmacología , Fosfatasa Ácida/metabolismo , Animales , Citoplasma/enzimología , Resistencia a Medicamentos , Células Gigantes/enzimología , Procesamiento de Imagen Asistido por Computador , Masculino , Osteoclastos/enzimología , Ratas , Reproducibilidad de los Resultados , Tibia/citología , Vacuolas/enzimología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA